don’t fuck with your cholesterol levels.
Dalcetrapib, a CETP inhibitor that raises HDL cholesterol, just failed for Roche: Effects of dalcetrapib in patients with a recent acute coronary syndrome (Schwartz et al., 2012)
Not surprisingly, as Pfizer’s version also failed 5 years ago: Effects of of torcetrapib in patients at high risk for coronary events (Barter et al., 2007)
must read –> …if it ain’t broke…
